We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
 

RELATED ARTICLES

Reducing Heart Attack-induced Tissue Damage by 30%

News

Scientists have discovered that inhibiting the synthesis of a lipid in a mouse suffering a heart attack reduces the tissue damage by 30%.

READ MORE

Powerful Technique Tracks Down Genetic Disease

News

A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases. The new method compares activity levels of maternal and paternal alleles across the genome and detects when the activity of an allele lies far enough outside the normal range to be a plausible cause of disease.

READ MORE

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE